Chlamydial infection is an important source of gynaecological morbidity, being commonly associated with acute and chronic pelvic inflammatory disease and therefore infertility." Both problems have a large impact on the provision of gynaecological services in a given area. Screening and treatment for chlamydial infection before transcervical instrumentation that breaches the internal cervical os may prevent iatrogenic pelvic inflammatory disease,'4 especially when retained products of conception within the uterine cavity provide an ideal medium for bacterial growth. We think that in cases of termination of pregnancy our results justify prior screening for chlamydia in the west of Scotland and in other areas with similar prevalence rates. If screening facilities are lacking, prophylaxis may be justified. Screening has been endorsed by workers elsewhere in the United Kingdom.'
The high percentage of women with asymptomatic genital chlamydial infection makes the use of effective antibiotics-for example, a tetracycline or erythromycin-important in cases of pelvic inflammatory disease and suspected postpartum and postabortion endometritis. Treatment of the partners of patients with genital chlamydial infection is recommended in order to prevent reinfection and reduce the pool of genital chlamydial strains within the general population. For the gynaecologist this may entail shared management with the genitourinary physicians. In our study the prevalence of other sexually transmitted diseases was very low, which may reflect regional differences. This low prevalence, however, should not be regarded as unimportant.
We have detected a high incidence of chlamydial infection in both general practice and colposcopy clinics in Glasgow. General practitioners and gynaecologists should be more aware of the importance of investigating and treating chlamydial infection in both asymptomatic women and their partners. The statistical analysis system (SAS)" was used for data processing, and statistical modelling was performed with the epidemiological graphics, estimation, and testing package (EGRET)." Mortality among the whole cohort was analysed by log linear Poisson regression models and adjusted for age by fitting separate variables for each single year of age at examination.
More complex analyses including continuous variables were conducted by a "nested" (within the cohort) case-control approach. Cases were defined as men who died of cerebrovascular disease (ICD8 [430] [431] [432] [433] [434] [435] [436] [437] [438] during the 18 years of follow up. Matched controls were selected for each case from among the men who survived longer than the subjects who died from the date of examination. The matching criteria were age at examination (single years), height (measured to the nearest half inch (1 3 cm)), and smoking habit (never, former, or current smoker). All 16 6 years of follow up. Table I shows the distribution of deaths due to stroke by age at death and certified underlying cause of death.
Six out of 69 men with atrial fibrillation at entry died compared with the figure of 1-3 expected deaths according to the age specific rates in the remainder of the cohort (rate ratio 4-6; 95% confidence interval 2-1 to 10 5). Inclusion of men with atrial fibrillation in subsequent case-control analyses resulted in failure to attain convergence in some of the models fitted. These six men and one other man whose electrocardiogram was not recorded at entry were therefore excluded from the remainder of the analyses.
Tobacco smoking at entry was associated with fatal stroke among men with sinus rhythm. The age adjusted rate ratios for current smokers compared with lifelong non-smokers were 1-38 (95% confidence interval 0 96 to 2 00) for all deaths due to stroke, 2 21 (1-28 to 3 84) for fatal strokes occurring before age 70, and 0-89 (0-38 to 2 08) for fatal strokes occurring after age 70. The corresponding rate ratios for former smokers compared with lifelong non-smokers were 1 02 (0-68 to 1-48), 1 59 (0-89 to 2 82), and 0 64 (0 37 to 1 10).
CASE-CONTROL ANALYSES
The case-control study was based on 261 patients and 3247 controls matched for age, height, and smoking habit. The number of controls ranged from one to 34 per case. In all, 111 (43%) cases had fewer than 10 matched controls, but only 51 (20%) had fewer than five matched controls. No controls could be matched to one man (height 152 cm) who died of subarachnoid haemorrhage. Table I gives the other patients who were excluded because of missing data or atrial fibrillation at entry.
In single factor conditional logistic regression models fatal stroke was significantly more common among those with a low FEV1. The rate ratio per litre decrease in FEVy (controlling for age, height, and smoking habit by matching) was 1 46 (95% confidence interval 1-16 to 1-84, x2= 10 3, df= 1). Inclusion of a quadratic term for FEV1 did not significantly improve the fit of the model (x2= 1 -56, df= 1). The relation of forced vital capacity to death caused by stroke was of a similar strength (rate ratio= I -42/litre decrease, confidence interval 1-13 to 1 80) but was less significant (X2=8-68, df= 1). There was a weak association between fatal stroke and the ratio of FEV1 to forced vital capacity (rate ratio=1 09 per 10% decrease, 0 95 to 1 25, x2=1-42, df= 1).
As expected, raised blood pressure was strongly related to mortality due to stroke. Taken individually, systolic blood pressure was a more powerful predictor offatal stroke, as judged by the likelihood ratio statistic (X2 = 113 7, df= 1) than was phase IV diastolic pressure (X2=92-3, df=l). When modelled jointly, however, the effect ofdiastolic pressure was significant (x2= 7*58, df= 1) after adjustment for systolic pressure. Quadratic terms for systolic (X2 -3-38, df= 1) or diastolic pressure (X2=2S59, df=l) did not significantly improve the model, but terms describing their interaction with age at death (above or below 70 years) were jointly significant (X2 =7-13, df= 2). Four terms were therefore used in subsequent analyses to adjust for the effects of blood pressure on mortality due to stroke: linear terms for systolic and diastolic pressure, each for deaths among men above and below 70 years of age.
When FEV1 was added to this model its effect was similar to that obtained before adjustment for blood pressure. The rate ratio/litre decrease in FEV, was 141 (95% confidence interval 1-12 to 179), which remained highly significant (x=8 11, df=1). Table II gives the rate ratios for blood pressure and FEV, by age at death due to stroke. Although a low FEV1 was more strongly associated with fatal stroke occurring in men before age 70 than with deaths due to cerebrovascular causes in older men, the interaction between FEV, and age at death was not significant (x2=288, df= 1). There was no significant difference in the degree ofassociation of reduced FEV, with subarachnoid haemorrhage, cerebral haemorrhage, and other types of stroke (X2 for interaction= 3-27, df=2). The tRate ratios before adjustment differ because of missing data for certain variables. Number of cases and controls varied from 261/3247 for body weight to 252/3129 for plasma cholesterol. t"Low" grades-clerical and messenger grades; "high" grades-administrative, professional, and executive. Civil servants in the British Council and Diplomatic Service are excluded from these classifications.
5Blood glucose measured two hours after 50 g glucose load. Glucose tolerance categories defined as "normal"-below 95% centile point (5-4 mmol/l); "intolerant"-5-4-11-0 mmol/l; "diabetic"--11-1 mmolUl. Previously diagnosed diabetic subjects are included in the "diabetic" group. |iMinnesota codes for Q/QS waves (1-1-1-3), ST depression (4-1-4-4), T wave inversion or flattening (5-1-5-3), or left bundle branch block (7-1).
term to describe the effect of FEVy on mortality due to stroke. The effect of other cardiovascular risk factors on the risk of fatal stroke and the association between low FEV1 and mortality due to stroke was investigated by adding them, in turn, to a "core model" consisting of the four blood pressure terms (shown in table II) plus FEV1. Table III shows the adjusted rate ratio estimates for each risk factor with associated 95% confidence intervals and likelihood ratio x: statistics. None of the risk factors were significantly associated with fatal stroke at the 5% level, although the rate ratio for history of intermittent claudication was of borderline significance (p=0 06). The changes in the rate ratio for FEV1 when each cardiovascular risk factor was included in the model were small, indicating minimal confounding by these variables of the association between FEVy and stroke (table III) .
CLINICAL PREDICTION OF FATAL STROKE
The value of measurements of blood pressure and ventilatory function in clinically predicting fatal stroke was investigated among all men with sinus rhythm at entry. Table IV gives the mortality ratios (relative to 100 for all men) by tertiles of systolic blood pressure and tertiles of FEV1 (as measured), adjusting for age alone and for age, smoking habit, and employment grade.
In each third of the distribution of systolic blood pressure men in the lowest third of the distribution of FEV1 had higher age adjusted mortality due to stroke. The interaction between systolic blood pressure and FEV1 was not significant (X2=3-56, df=4, adjusting for age alone). Comparing men with FEV1 <3 litres with those whose FEVy was Bit3 5 litres, the rate ratio adjusted for age (single years) and tertile of systolic blood pressure was 1-88 (95% confidence interval 1 32 to 2 69). After further adjustment for smoking habit and employment grade the corresponding rate ratio was 170 (1-18 to 246).
A non-significant excess of deaths due to stroke remained among the current cigarette smokers, independent of age, employment grade, tertile of systolic blood pressure, and tertile of FEV, (rate ratio= 1 32 compared with lifelong non-smokers, 95% confidence interval 0 91 to 1-92). The rate ratio for men in "low" employment grades compared with those in "high" grades, adjusted for age, smoking, tertile of systolic blood pressure, and tertile of FEV1, was 1-20 (0-92 to 1-58).
Discussion
Recent reviews do not mention impaired ventilatory function as a possible risk factor for cerebrovascular disease.'7 18 The results presented here, considered alongside the findings of previous studies,2 69 suggest that this may be an important omission. The association between spirometric indices and stroke can be con- 
